Healthcare Leaders Income ETF (HHL-T)

Paying about 99 bps MER for a covered call strategy, giving you a 9-10% dividend yield. A lot of investors are really attracted to that yield. But when you compare the covered call strategy against the underlying securities, you'll find that a lot of the time you'll do better just owning the underlying healthcare index. Covered calls mean you get struck out without realizing some of the upside of names in the portfolio.

If you need the income, fine. If not, just own the underlying stocks or index -- pay less in management fees, capture upside. Over time, that will give you a better total return.

He does own healthcare, but in a very specific space. See his Top Picks. Healthcare is fairly undervalued compared to history, mainly because we have many different industries within the healthcare space. Big pharma, biotech, distributors, medical devices, etc. Some are doing extremely well, and some not at all. 

They are both relatively safe or stable sectors so you could add both to your portfolio.

It has had the same distribution for the past 10 years and is one of the top performers in the market. It has equity risk with some volatility but pays a consistent monthly distribution. Holds 20 large cap companies with maybe only a couple of changes per year.

A covered call ETF so it provides extra income. He's recommended it before. 

The unhedged stock. Is covered call, boosting yield. Healthcare stocks have sold off, like Eli Lilly, though ISRG has done well. Is a lot of change in healthcare amid the change in presidents. So, this sector is sadly on the back burner. If you hold it, you get paid a good dividend as you wait.

A good product that can be held. Would recommend as a portion of portfolio. Not a capital appreciation strategy - covered call reduces ability for share to appreciate. 

Great option for income oriented investors. However, would recommend diversifying with other names in portfolio. Overall direction of healthcare sector is strong. 

Good for healthcare exposure with dividend. Won't get high capital gains. But is a reliable product. 

Blue-chip basket of US healthcare names. Covered calls and leverage. Covered calls trade potential upside for potential income. If investor's ACB has gone down, could be because of return of capital.

The Harvest covered call ETFs start well, but then flatline. So, he has sold all his Harvest ETFs.

Healthcare sector lagging in the market, and is due for an increase in value. Very large companies with tailwind in aging population/demand for healthcare. Covered call strategy adds to yield. Good option for investors going forward. 

It was strictly a yield play when interest rates were so low. He has only a small position. Growth in the ETF can be somewhat restrained by the covered call structure. It's a tradeoff between yield and growth. He's still bullish on the healthcare sector, the demographics are beautiful.

Very good for healthcare exposure.
Actively managed with good performance.
High dividend yield (~10%).
Good for long term investors.